TXMD TherapeuticsMD, Inc.

5.69
-0.02  -0%
Previous Close 5.71
Open 5.72
Price To book 10.27
Market Cap 1.16B
Shares 203,927,000
Volume 1,331,143
Short Ratio 19.16
Av. Daily Volume 3,446,250

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released December 5, 2016. NDA filing due 3Q 2017.
TX-001HR
Moderate to severe vasomotor symptoms (VMS)
CRL announced May 8, 2017. Company noted that FDA cited a lack of long-term endometrial safety data.
Yuvvexy
Moderate-to-severe vaginal pain

Latest News

  1. TherapeuticsMD, Inc. – Value Analysis (NYSE MKT:TXMD) : June 20, 2017
  2. DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm
  3. DEADLINE TODAY: TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017
  4. FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017
  5. Are Options Traders Betting on a Big Move in TherapeuticsMD (TXMD) Stock?
  6. TherapeuticsMD, Inc. breached its 50 day moving average in a Bullish Manner : TXMD-US : June 19, 2017
  7. JUNE 19 DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm
  8. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TherapeuticsMD, Inc. of Class Action Lawsuit and Upcoming Deadline - TXMD
  9. DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 -- TXMD
  10. DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017
  11. MONDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm
  12. EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc.
  13. 5-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm
  14. UPCOMING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm
  15. INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and Lead Plaintiff Deadline of June 19, 2017 -- TXMD
  16. TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017
  17. INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017
  18. EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm